|
|
|
| Central Pulp to convene EGM to approve name change of the Company |
| Central Pulp Mills Ltd has informed BSE that Extra Ordinary General Meeting (EGM) of the Company will be held on November 02, 2001 to approve change in name of the company to JK Paper Ltd.
|
| Mastek Q1 net down by 76.82% |
| Mastek Ltd has posted a net profit of Rs 16.20 million for the quarter ended September 30, 2001 as compared to Rs 69.90 million for the quarter ended September 30, 2000. Total Income for the quarter ended September 30, 2001 is at Rs 198.10 million as compared to Rs 250.80 million for the quarter ended September 30, 2000.
|
| High Court orders Rallis India to seek shareholders approval for the scheme of amalgamation |
| Rallis India Ltd has informed BSE that, the Hon'ble High Court at Bombay has given order for convening the meeting of Equity Shareholders on October 30, 2001 to consider Scheme of Amalgamation of Rallis Finance and Investments Ltd, Rallis Farm Management Services Ltd, Rallis Hybrid Seeds Ltd., Ralchem Ltd. and Sankhya Garments Ltd. with the company.
|
| HCL Info Q1 results on October 18, 2001 |
| HCL Infosystems Ltd has informed BSE that a meeting of the Board of the Directors of the Company is scheduled to be held on October 18, 2001 to inter alia, take on record the unaudited results of the Company for the three months ended on September 30, 2001.
|
| Devaki Hospital Board recommends 5% interim dividend for FY-02 |
| Devaki Hospital Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 10, 2001 have decided to pay interim dividend for the year 2001-02 @ 5% on the paid up share capital of the Company for the year 2001-02.
|
| BASF H1 on October 31, 2001 |
| BASF India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 31, 2001 to consider and take on record inter alia the unaudited financial results for the half year ended September 30, 2001.
|
| GlaxoSmithkline to spend Rs 752.8 million towards VRS |
| GlaxoSmithkline Pharmaceuticals Ltd has informed BSE that the Company has accepted applications for Voluntary Retirement from 622 employees and will have to pay a total sum of Rs 752.8 million (Approximately) towards their separation cost.
|
| GlaxoSmithKline Q3 results on October 25, 2001 |
GlaxoSmithkline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company has been scheduled to be held on October 25, 2001 to consider among other things, approval of unaudited financial results for the quarter ended September 30, 2001.
Since SmithKline Beecham Pharmaceuticals India Ltd has merged with the Company, combined results will be published for the quarter ended September 30, 2001.
|
| Silverline's GuestLogix Services Engine to Power AskInFlight's B2B eProcurement Service
|
Silverline Technologies Ltd, an international software development and integration services firm, announced today (October 10, 2001) that its eHospitality divisions has reached agreement with AskInFlight regarding the use of Silverline's GuestLogix™ Services Engine. Under the terms of the agreement AskInflight will use GuestLogix as the basis for its eProcurement service offering to the in-flight services industry.
AskInFlight offers airlines and in flight service providers a robust B2B portal solution to their procurement needs. The portal facilitates eProcurement by serving as a platform where airlines can review the offerings of multiple vendors and initiate transactions from the site. AskInFlight also has the capability to host online auctions of in-flight goods and services. The latest value added service offered by AskInFlight is an application service provider (ASP) offering to airlines that do not want to maintain the technical infrastructure associated with in-flight services.
Silverline's GuestLogix is a suite of components that can be configured to help airlines manage their in-flight services. With GuestLogix, an airline can design their in-flight services system, plan the specific services to be offered on a given flight, forecast their in-flight goods and services requirements, audit the invoices of suppliers and finally export the data to a back-office system. The software can be quickly implemented because it incorporates pre-built connectors to ERP, CRM and supply-chain applications.
|
| DSQ Software SQ-01 results on October 23, 2001 |
| DSQ Software Ltd has informed BSE that a meeting of the Board of Directors of the Company has been scheduled to be held on October 23, 2001 to consider, inter alia, unaudited Financial results of the Company for the quarter ended September 30, 2001.
|
| Lock out at Govind Rubber's Bhiwadi factory lifted |
| Govind Rubber Ltd has informed BSE that, lock out at its Bhiwadi Factory has been lifted subsequently on September 27, 2001 and at present the operation of the factory is closed.
|
| Members of Eskay K'n'IT cancel 10% dividend for FY-01 |
| Eskay K'n'IT India Ltd has informed BSE that in the AGM of the company held on September 28, 2001, the members resolved to skip the dividend of 10% for the year ended March 31,2001 as recommended by the Board of Directors.
|
| Ponni Sugars Fin Committee to consider modified demerger scheme
|
Ponni Sugars & Chemicals Ltd (PSCL) has informed BSE that the Finance Committee of the Board of Directors is scheduled to meet on October 12, 2001 to consider the demerger scheme as modified & sanctioned by the High Court of Madras. The Finance Committee will also at the aforesaid meeting fix the record date for the purpose of determining the members of PSCL to get allotment of fresh equity shares of PSCL and PEL in place of their existing holding in PSCL.
Earlier the scheme of demerger of Erode Undertaking of the company by spinning it off to Ponni Sugars Erode Ltd (PEL) was approved by the shareholders at the court convened meeting held on April 07, 2000. Later the scheme was approved by the meetings of secured & unsecured creditors held on March 03, 2001 as per directions of the Madras High Court.
The Hon'ble High Court of Madras has since sanctioned the scheme by its order dt. 10/09/2001/ 26/09/2001.
The sanction of the demerger got held up owing to certain objections raised by one of the creditors namely State Bank of India before the High Court. The High Court after considering the objections of SBI has sanctioned the scheme with certain modifications.
The scheme envisages the issue of 2 equity shares of Rs 10 each in PEL for every 5 equity shares held in PSCL. Simultaneously the equity share capital of PSCL shall get reorganised by issue of 3 equity shares of Rs 10 each for every 5 equity shares held with concurrent cancellation of existing equity capital.
|
| Satyam Q2 results on October 24, 2001 |
Satyam Computer Services Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on October 24, 2001 to consider inter alia the audited financial results of the company for the quarter ended September 30, 2001.
In the aforesaid meeting if the Board of Directors considers and declares the interim dividend for the financial year 2001-02, the record date for this purpose will be November 09, 2001.
|
| Bharat Forge Q2 results on October 20, 2001 |
| Bharat Forge Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on October 20, 2001 to take on record the Unaudited Financial Results of the Company for the quarter ended on September 30, 2001
|
| High Court orders English Indian Clays to seek shareholders approval for scheme of reorganisation |
| English Indian Clays Ltd has informed BSE that, the Hon'ble High Court at Kerala has given order for convening the meeting of Equity Shareholders on November 02, 2001 to consider Scheme of Reorganisation by way of Arrangement, Amalgamation and Reconstruction between Bharat Starch Industries Ltd., Bilt Bio-Chemicals Ltd. with the company and Scheme of Reconstruction of Bharat Project Ltd. (subsidiary of the company) and their respective shareholders with the company.
|
| Members of Annamalai Finance approves issue of NCD on private placement basis |
| Annamalai Finance Ltd has informed BSE that at the EGM of the company held on September 08, 2001, members have approved the issue of Secured NCDs upto an amount of Rs.300 million by private placement and for such debentures to be issued and allotted to any person or persons, Companies, Banks or FIs whether or not those allottees are existing shareholders/debentureholders of the company.
|
| ABB Q3 results on October 23, 2001 |
| Asea Brown Boveri Ltd (ABB) has informed BSE that a meeting of the Board of Directors is scheduled to be held on October 23, 2001 to take on record the Unaudited Financial Results of the Company for the third quarter ended September 30, 2001.
|
| Ranbaxy's US subsidiary announces the market launch of Ibuprofen+Pseudoephedrine combination product |
Ohm Laboratories Inc, a wholly owned subsidiary of Ranbaxy Laboratories Ltd, achieved a commercial milestone with the first interstate shipments of Advil ®Cold and Sinus Tablets (Ibuprofen & Pseudoephedrine combination product) on October 08, 2001. The shipment was made by its marketing partner, Perrigo of Allergan, Michagin the largest store brand marketer in the US.
This commercial milestone represents another achievement for Ohm Laboratories who developed, filed and manufactured for this product. The company formed a strategic alliance with Perrigo to optimize the commercial value of this name brand equivalent. As per the partnership established Ohm will manufacture Ibuprofen & Pseudoephedrine tablets USP and Perrigo will market & distribute this product.
This private label store brand has been granted an AB rating to Whitehall Laboratories brand of Advil ® Cold and Sinus Tablets, which experienced retail sales in excess of $50.0 million in the year 2000. This over-the-counter product is indicated for the treatment of nasal congestion, headache, fever, body aches and pain.
As of today, all major retail outlets, including retail pharmacies, food combination outlets, and mass merchandisers, have now taken this product into inventory with sales anticipated to be available to consumers starting by the end of the month. It will be packaged in blisters of 10s and sold in 20 and 40 count packs that will emulate the packages available from the innovator. Since Ohm Laboratories was the first ANDA applicant to file an ANDA for this product, a 180 day marketing exclusivity has been granted as part of the approval.
In April 2001, Ohm Laboratories Inc. announced its approval from the US FDA to market Ibuprofen and Pseudoephedrine Hydrochloride tablets USP 200mg, and 30mg respectively.
|
| Essar Oil denies news item |
| With reference to the news article appearing in a leading financial daily titled " Essar drilling division to invest additional funds for exploration", Essar Oil Ltd has informed BSE that the contents of the article is factually incorrect. The caption gives an impression that drilling division would invest in exploration and development activities. The drilling division has no plans to invest Rs 1500 million in exploration and production. These divisions are independent of each other. While the drilling division is engaged in contract drilling activities primarily in the middle-east, the exploration and production division is engaged in exploration work.
|
| Wartsila India members approve amalgamation scheme |
| Wartsila India Ltd has informed BSE that, in the Court Convened General Meeting of the Company held on September 10, 2001, the members of the company have unanimously approved Scheme of Amalgamation of Wartsila Operations & Maintenance India Ltd. with the company.
|
| Philips Q3 results on October 19, 2001 |
| Philips India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 19, 2001 inter alia, to consider the Unaudited Financial Results of the Company for the third quarter ended September 30, 2001.
|
| Infosys Tech Q2 net profit up by 30.87%, declares interim dividend of Rs 7.50 per share |
Infosys Technologies Ltd has posted a net profit of Rs 2015.6 million for the quarter ended September 30, 2001 as compared to Rs 1540.10 million for the quarter ended September 30, 2000. Net sales have increased from Rs 4461 million in SQ 2000 to Rs 6501.3 million in the quarter ended September 30, 2001. Other income for SQ-01 is at Rs 146.6 million as against Rs 195.8 million in the quarter ended September 30, 2000.
The Board of Directors has recommended an interim dividend of Rs 7.50 per share of par value of Rs 5 ie an interim dividend of 150% for the financial year 2001-2002.
Outlook for the quarter ending December 31, 2001.
Income from Software development services & products expected to be between Rs 6400 million & Rs 6560 million.
Earnings per share expected to be between Rs 29 & Rs 31.
Outlook for the fiscal year ending March 31, 2002.
Income from Software development services & products expected to be between Rs 25400 million & Rs 25900 million.
Earnings per share expected to be between Rs 120 & Rs 123.
|
| Balaji Telefilms to consider interim dividend, Q2 results on Oct 24, 2001 |
| A meeting of the Board of Directors of Balaji Telefilms Ltd is convened on October 24, 2001 to consider amongst other items of agenda, the un-audited financial results of the company for the quarter & half-year ended September 30, 2001 and declaration of interim dividend on equity shares. The dividend, if declared will be paid to the shareholders within a stipulated period prescribed under the Companies Act, 1956.
|
| Infosys Tech announces results as per GAAP standards |
Infosys Technologies Ltd has announced results for the quarter ended September 30, 2001 as per GAAP standards. The figures are in US$.
Particulars Qtr ended Sept 2001 Qtr ended Sept 2000
Net Profit as per Indian GAAP 42,543,746 33,865,614
Amortization of deferred stock Composition exp (1,251,327) (1,275,796)
Deferred taxes - 192,068
Net Income as Per US GAAP 41,292,419 32,781,886
|
| IPCL Board meeting to consider H1 results rescheduled on October 31, 2001 |
|
Indian Petrochemicals Corporation Ltd has informed BSE that the Board of Directors of the company will now meet on October 31, 2001 instead of October 27, 2001 to consider & take on record the unaudited financial results of the company for the half year ended September 30, 2001.
|
|